Archives
-
GDC-0941 Workflows for PI3K/Akt Cancer Studies
2026-08-25
GDC-0941 provides a practical way to connect PI3K/Akt pathway inhibition with phospho-Akt, viability, apoptosis, and cancer stem cell assays. This guide translates its α/δ-biased activity into reproducible workflows for resistant cancer models while highlighting controls, dosing logic, and troubleshooting priorities.
-
S63845: A Strategic MCL1 Inhibitor for Translation
2026-08-25
S63845 turns MCL1 biology into a practical translational research strategy: connect nanomolar target engagement to BAX/BAK-dependent apoptosis, define combination logic, and set disciplined preclinical decision gates. This thought-leadership perspective places S63845 within hematological cancer research while examining how evidence from pancreatic cancer models may inform rational pathway co-targeting.
-
Western Secondary Antibody Dilution Buffer Guide
2026-08-24
Optimize macrophage atherosclerosis immunoblots with a secondary antibody dilution buffer designed to limit background and preserve diluted antibody performance. This practical guide connects NHE1/Olfr2 pathway biology with reproducible Western blot workflows, reuse planning, and troubleshooting.
-
Moxifloxacin Workflows for Gyrase and Toxicity Studies
2026-08-24
Build a connected workflow with Moxifloxacin that moves from DNA gyrase-oriented assays to retinal-cell viability and systemic metabolic readouts. Practical dosing, fresh-solution handling, orthogonal endpoints, and troubleshooting guidance help distinguish antibacterial mechanism from compound-associated toxicity.
-
AG-126: ERK Testing in NLGN1 Circuit Models
2026-08-23
AG-126 (Tyrphostin AG-126) provides a pharmacological route to test ERK1/2 signaling in cellular models of NLGN1-related repetitive behavior. This article distinguishes established inflammatory evidence from a carefully bounded neurobiology hypothesis and translates the distinction into practical assay decisions.
-
Guanabenz Acetate in Stress-Pathway Assays
2026-08-22
Guanabenz Acetate enables receptor-defined perturbation of α2-adrenergic signaling while researchers examine stress-granule and innate-immune phenotypes. This article connects product chemistry with the GADD34–IRF3 mechanism reported in SARS-CoV-2 research and develops a rigorous assay-design framework.
-
Primidone: TRPM3 and RIPK1 Workflows
2026-08-22
Primidone, also known as Mysoline, is a concentration-sensitive research probe that connects TRPM3 channel biology with RIPK1 pathway studies. This guide translates its documented pharmacology into practical cellular, biochemical, and animal-model workflows while highlighting solvent, dosing, and interpretation safeguards.
-
Early Life Adversity, Oxytocin, and Innate Defense
2026-08-21
Tan and colleagues identify a circuit-level mechanism by which early life adversity impairs looming-evoked innate defensive behavior in mice: reduced oxytocin signaling in the intermediate and deep layers of the superior colliculus. The study combines developmental stress modeling, receptor manipulation, pathway analysis, and intranasal oxytocin rescue to connect early experience with altered threat processing.
-
Cyclo (-RGDfC) in Spatial Hydrogel Assays
2026-08-20
Use Cyclo (-RGDfC) to connect αvβ3 integrin biology with spatially defined, 96-well hydrogel experiments. An open-platform digital light printer adds reproducible gel geometry and localized patterning, while careful DMSO handling, vehicle controls, and receptor-aware validation improve assay reliability.
-
AZD1480: Practical JAK2 Inhibitor Workflows
2026-08-20
AZD1480 supports mechanism-first cancer assays that connect JAK2 phosphorylation, STAT3 signaling, apoptosis, and tumor-cell behavior. Its value is especially clear in myeloma models and immune–tumor co-cultures, where pathway blockade can test whether inflammatory signals create tumor-protective resistance.
-
Taraxasterol, Necroptosis, and Osteoporosis in BMSCs
2026-08-19
A 2025 Phytomedicine study identifies taraxasterol as a regulator of necroptosis and osteogenic–adipogenic imbalance in bone marrow mesenchymal stem cells through the PI3K/AKT/PPARγ axis. By combining an ovariectomized mouse model with patient-derived BMSC experiments and multi-omics and target-validation methods, the work provides a mechanistic framework for connecting cell death, mitochondrial injury, and impaired bone formation.
-
CCK-8 Ammonium: From Receptor Biology to Translation
2026-08-19
Cholecystokinin octapeptide ammonium is more than a neuropeptide reagent. Its sulfation-dependent activity, CCK1R and CCK2R signaling, and context-sensitive effects create a useful framework for connecting zebrafish behavior with neuronal, immune, and cardiovascular research while keeping translational claims evidence-based.
-
SEMA3E, β-Catenin, and Beige Fat Thermogenesis
2026-08-18
A 2026 mouse study identifies SEMA3E as a positive regulator of beige adipocyte differentiation and thermogenesis in inguinal white adipose tissue. By combining genetic manipulation, adipose transplantation, RNA sequencing, mitochondrial respiration assays, and pathway rescue experiments, the work connects SEMA3E with oxidative phosphorylation and context-dependent Wnt/β-catenin signaling.
-
ALKBH5 Lactylation in Antiviral Innate Immunity
2026-08-18
The reference study identifies ALKBH5 lactylation as a previously unrecognized regulatory mechanism that strengthens innate immune responses to HSV-1, KSHV, and mpox virus. Its findings connect ESCO2 and SIRT6 to ALKBH5-dependent m6A demethylation of IFN-β mRNA, providing a mechanistic framework for understanding how posttranslational modification limits DNA-virus replication.
-
Fangchinoline, TFEB, and H1N1 Lysosomal Defense
2026-08-17
The reference study identifies fangchinoline as a lysosome-targeting antiviral candidate that activates TFEB, restores lysosomal gene expression, and interferes with H1N1 entry. Its combination of Connectivity Map screening, transcriptomic analysis, organelle assays, time-resolved infection experiments, and in vivo validation provides a useful framework for studying host-directed antiviral mechanisms.